<!DOCTYPE html>
<html lang="en"><head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1"><!-- Begin Jekyll SEO tag v2.6.1 -->
<title>Predicting progression &amp; cognitive decline in amyloid-positive patients with Alzheimer’s disease | Healthy AI Lab</title>
<meta name="generator" content="Jekyll v3.9.0" />
<meta property="og:title" content="Predicting progression &amp; cognitive decline in amyloid-positive patients with Alzheimer’s disease" />
<meta name="author" content="Hákon Valur Dansson, Lena Stempfle, Hildur Egilsdóttir, Alexander Schliep, Erik Portelius, Kaj Blennow, Henrik Zetterberg, Fredrik D Johansson" />
<meta property="og:locale" content="en_US" />
<meta name="description" content="Abstract" />
<meta property="og:description" content="Abstract" />
<link rel="canonical" href="http://localhost:4000/blog/2021/03/15/adni-prediction.html" />
<meta property="og:url" content="http://localhost:4000/blog/2021/03/15/adni-prediction.html" />
<meta property="og:site_name" content="Healthy AI Lab" />
<meta property="og:image" content="http://localhost:4000/assets/posts/mmse_change.png" />
<meta property="og:type" content="article" />
<meta property="article:published_time" content="2021-03-15T09:00:00+01:00" />
<script type="application/ld+json">
{"datePublished":"2021-03-15T09:00:00+01:00","headline":"Predicting progression &amp; cognitive decline in amyloid-positive patients with Alzheimer’s disease","mainEntityOfPage":{"@type":"WebPage","@id":"http://localhost:4000/blog/2021/03/15/adni-prediction.html"},"url":"http://localhost:4000/blog/2021/03/15/adni-prediction.html","author":{"@type":"Person","name":"Hákon Valur Dansson, Lena Stempfle, Hildur Egilsdóttir, Alexander Schliep, Erik Portelius, Kaj Blennow, Henrik Zetterberg, Fredrik D Johansson"},"image":"http://localhost:4000/assets/posts/mmse_change.png","description":"Abstract","@type":"BlogPosting","dateModified":"2021-03-15T09:00:00+01:00","@context":"https://schema.org"}</script>
<!-- End Jekyll SEO tag -->
<link rel="stylesheet" href="/assets/main.css"><link type="application/atom+xml" rel="alternate" href="http://localhost:4000/feed.xml" title="Healthy AI Lab" /></head>
<body><header class="site-header" role="banner">
  <div class="wrapper"><div class="site-title">
      <a rel="author" href="/">Healthy AI Lab<br/></a>
      <div class="site-subtitle">at Chalmers University of Technology</div>
    </div>

    <nav class="site-nav">
      <input type="checkbox" id="nav-trigger" class="nav-trigger" />
      <label for="nav-trigger">
        <span class="menu-icon">
          <svg viewBox="0 0 18 15" width="18px" height="15px">
            <path d="M18,1.484c0,0.82-0.665,1.484-1.484,1.484H1.484C0.665,2.969,0,2.304,0,1.484l0,0C0,0.665,0.665,0,1.484,0 h15.032C17.335,0,18,0.665,18,1.484L18,1.484z M18,7.516C18,8.335,17.335,9,16.516,9H1.484C0.665,9,0,8.335,0,7.516l0,0 c0-0.82,0.665-1.484,1.484-1.484h15.032C17.335,6.031,18,6.696,18,7.516L18,7.516z M18,13.516C18,14.335,17.335,15,16.516,15H1.484 C0.665,15,0,14.335,0,13.516l0,0c0-0.82,0.665-1.483,1.484-1.483h15.032C17.335,12.031,18,12.695,18,13.516L18,13.516z"/>
          </svg>
        </span>
      </label>

      <div class="trigger"><a class="page-link" href="/about/">About</a><a class="page-link" href="/code/">Code &amp; data</a><a class="page-link" href="/news/">News</a><a class="page-link" href="/people/">People</a></div>
    </nav>

  </div>
</header>
<main class="page-content" aria-label="Content">    
      


<div class="wrapper">
  <article class="post h-entry" itemscope itemtype="http://schema.org/BlogPosting">

    <header class="post-header">
      <h1 class="post-title p-name" itemprop="name headline">Predicting progression &amp; cognitive decline in amyloid-positive patients with Alzheimer&#39;s disease</h1><p>
          <span itemprop="author" itemscope itemtype="http://schema.org/Person"><span class="p-author h-card" itemprop="name">Hákon Valur Dansson, Lena Stempfle, Hildur Egilsdóttir, Alexander Schliep, Erik Portelius, Kaj Blennow, Henrik Zetterberg, Fredrik D Johansson</span></span>
        </p>
        <p><span class="p-venue h-card" itemprop="name">Alzheimer's Research & Therapy
          
            <a href="https://alzres.biomedcentral.com/articles/10.1186/s13195-021-00886-5" target="_blank">[Paper URL]</a>
          
        </span></p>
      
    </header>


    <div class="post-content e-content" itemprop="articleBody">
      <h3 id="abstract">Abstract</h3>

<p><img src="/assets/posts/mmse_change.png" alt="Change in MMSE over time" class="post-general-image" /></p>

<p>In Alzheimer’s disease, amyloid-β (Aβ) peptides aggregate in the brain forming CSF amyloid levels, which are a key pathological hallmark of the disease. However, CSF amyloid levels may also be present in cognitively unimpaired elderly individuals. Therefore, it is of great value to explain the variance in disease progression among patients with Aβ pathology. We studied the problem of predicting disease progression and cognitive decline of potential AD patients with established Aβ pathology using the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database.
A cohort of n=2293 participants, of whom n=749 were Aβ positive, was selected from the to study heterogeneity in disease progression for individuals with Aβ pathology. Aβ pathology status was determined based on the Aβ42/Aβ40 ratio. Due to the relatively low prevalence of Aβ pathology, models fit only to Aβ-positive subjects were compared to models fit to an extended cohort including subjects without established Aβ pathology, adjusting for covariate differences between the cohorts.</p>

<p>The best performing machine learning model achieved a performance of R2 = 0.388 predicting the change in MMSE scores two years after baseline using a linear regression model based on a cohort with weighted samples in the training cohort using all features at baseline. Similarly, a gradient boosting model with all subjects weighted equally predicted the change in diagnosis with high accuracy (F1 = 0.791) when using all features. For the most accurate predictions, our models combine variables measured at the baseline such as cognitive tests, CSF biomarkers, proteins and genetic markers. Among these, baseline cognitive tests scores were found to be the strongest predictors, accounting for most of the variance explained by all features, across models. Finally, we identified that even though the Aβ42/Aβ40 ratio is a good predictor for AD in the preclinical phase, the respective levels of Aβ are less useful in predicting progression among only Aβ-positive subjects. Baseline assessments of cognitive function accounts for the majority of variance explained in the prediction of two-year decline but is insufficient for achieving optimal results in longer-term predictions.</p>

    </div><a class="u-url" href="/blog/2021/03/15/adni-prediction.html" hidden></a>
    <p class="post-meta">
      <time class="dt-published" datetime="2021-03-15T09:00:00+01:00" itemprop="datePublished">Mar 15, 2021
      </time>
    </p>
  </article>
</div>

    </main><footer class="site-footer h-card">
  <data class="u-url" href="/"></data>

  <div class="wrapper">

    <!--<h2 class="footer-heading">Healthy AI Lab</h2>-->

    <div class="footer-col-wrapper">
      <div class="footer-col footer-col-1">
        <!---->
        <!--
        <ul class="contact-list"><li>Contact:</li>
          <li><a class="u-email" href="mailto:fredrik.johansson@chalmers.se">fredrik.johansson@chalmers.se</a></li></ul>-->
      </div>

      <div class="footer-col footer-col-2">

      </div>
    </div>

  </div>

</footer>
</body>

</html>
